Catalyst Pharmaceuticals (CPRX) EBIT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.41% |
| Dec 31, 2025 | -6.67% |
| Sep 30, 2025 | -0.05% |
| Jun 30, 2025 | 4.63% |
| Mar 31, 2025 | 0.83% |
| Dec 31, 2024 | 23.44% |
| Sep 30, 2024 | -6.15% |
| Jun 30, 2024 | 99.98% |
| Mar 31, 2024 | -34.94% |
| Dec 31, 2023 | 212.11% |
| Sep 30, 2023 | -179.63% |
| Jun 30, 2023 | 31.14% |
| Mar 31, 2023 | 15.61% |
| Dec 31, 2022 | 22.70% |
| Sep 30, 2022 | -12.14% |
| Jun 30, 2022 | 64.51% |
| Mar 31, 2022 | 36.29% |
| Dec 31, 2021 | -9.01% |
| Sep 30, 2021 | -11.58% |
| Jun 30, 2021 | 61.60% |
| Mar 31, 2021 | 13.73% |
| Dec 31, 2020 | -26.37% |
| Sep 30, 2020 | 13.83% |
| Jun 30, 2020 | -3.91% |
| Mar 31, 2020 | 33.64% |
| Dec 31, 2019 | -42.17% |
| Sep 30, 2019 | 26.33% |
| Jun 30, 2019 | 1,209.49% |
| Mar 31, 2019 | 93.35% |
| Dec 31, 2018 | -81.40% |
| Sep 30, 2018 | -29.15% |
| Jun 30, 2018 | -6.78% |
| Mar 31, 2018 | -7.65% |
| Dec 31, 2017 | -27.98% |
| Sep 30, 2017 | -3.00% |
| Jun 30, 2017 | 10.65% |
| Mar 31, 2017 | -8.48% |
| Dec 31, 2016 | -10.22% |
| Sep 30, 2016 | 18.70% |
| Jun 30, 2016 | 22.81% |
| Mar 31, 2016 | -0.74% |
| Dec 31, 2015 | -23.40% |
| Sep 30, 2015 | -2.45% |
| Jun 30, 2015 | -14.11% |
| Mar 31, 2015 | -7.73% |
| Dec 31, 2014 | 3.05% |
| Sep 30, 2014 | -37.42% |
| Jun 30, 2014 | 14.77% |
| Mar 31, 2014 | -29.61% |
| Dec 31, 2013 | 16.60% |
| Sep 30, 2013 | -22.32% |
| Jun 30, 2013 | -55.59% |
| Mar 31, 2013 | -13.29% |
| Dec 31, 2012 | -17.27% |
| Sep 30, 2012 | -20.27% |
| Jun 30, 2012 | 21.79% |
| Mar 31, 2012 | 32.92% |
| Dec 31, 2011 | -79.88% |
| Sep 30, 2011 | 19.07% |
| Jun 30, 2011 | 8.02% |
| Mar 31, 2011 | -107.50% |
| Dec 31, 2010 | 19.41% |